None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy male and female adults aged 19 to 80 years Healthy individuals (defined as those not currently receiving continuous treatment or medication for a chronic condition) Those who provide voluntary written informed consent after receiving a clear explanation of the purpose and characteristics of this clinical study
Exclusion criteria
Exclusion criteria: Those who have participated in another clinical trial involving an intervention within the past 4 weeks Those currently under treatment for unstable (uncontrolled) schizophrenia, bipolar disorder, or other psychiatric disorders diagnosed within the past 6 months Those diagnosed with and currently under treatment for a chronic respiratory disease (bronchial asthma, chronic obstructive pulmonary disease [COPD], bronchiectasis, sequelae of pulmonary tuberculosis, etc.) Those diagnosed with and under treatment for a serious chronic or terminal illness (malignant tumor, tuberculosis, chronic liver disease, interstitial pneumonia, chronic kidney disease, chronic heart disease, other rare metabolic diseases, etc.) Those judged unlikely to comply with protocol-required visits, treatments, or questionnaire completion Any other case deemed inappropriate for participation by the study personnel
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Perceived Stress Scale (PSS) score | — |
Secondary
| Measure | Time frame |
|---|---|
| Abdominal breathing performance data (respiration rate, breathing cycle, waveform stability index, waveform amplitude);Change in Pittsburgh Sleep Quality Index (PSQI) score;Change in Beck Depression Inventory (BDI) score;Change in State-Trait Anxiety Inventory (STAI) score;Change in State-Trait Anger Expression Inventory (STAXI) score;Change in Hwabyung Scale score;Change in Questionnaire of Cold-Heat Pattern Identification (QCHPI) score;Change in pulse diagnosis device (Canopy9) measurements;Change in Heart Rate Variability (HRV) indices;Application usage adherence (days used, total usage time, total sessions);Application user experience survey (overall satisfaction, usability, perceived usefulness);Occurrence of adverse events and safety | — |
Countries
Korea, Republic of
Contacts
Dong-eui University